{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:12:49Z","timestamp":1790784769575,"version":"4.1.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2007,3,13]],"date-time":"2007-03-13T00:00:00Z","timestamp":1173744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,3,13]],"date-time":"2007-03-13T00:00:00Z","timestamp":1173744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Angiogenesis"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1007\/s10456-007-9069-x","type":"journal-article","created":{"date-parts":[[2007,3,12]],"date-time":"2007-03-12T12:17:22Z","timestamp":1173701842000},"page":"141-148","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":87,"title":["Combination therapy for the treatment of ocular neovascularization"],"prefix":"10.1007","volume":"10","author":[{"given":"John","family":"Bradley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meihua","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory S.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,3,13]]},"reference":[{"key":"9069_CR1","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.yapd.2006.04.010","volume":"53","author":"A Drack","year":"2006","unstructured":"Drack A (2006) Retinopathy of prematurity. Adv Pediatr 53:211\u2013226","journal-title":"Adv Pediatr"},{"key":"9069_CR2","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/sj.eye.6701476","volume":"18","author":"R Williams","year":"2004","unstructured":"Williams R, Airey M, Baxter H, Forrester J, Kennedy-Martin T, Girach A (2004) Epidemiology of diabetic retinopathy and macular oedema: a systematic review. Eye 18:963\u2013983","journal-title":"Eye"},{"key":"9069_CR3","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1001\/archopht.122.7.1019","volume":"122","author":"DS Friedman","year":"2004","unstructured":"Friedman DS, O\u2019Colmain BJ, Munoz B, Tomany SC, McCarty C, de Jong PT, Nemesure B, Mitchell P, Kempen J (2004) Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 122:564\u2013572","journal-title":"Arch Ophthalmol"},{"key":"9069_CR4","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1136\/bjo.86.7.716","volume":"86","author":"I Kocur","year":"2002","unstructured":"Kocur I, Resnikoff S (2002) Visual impairment and blindness in Europe and their prevention. Br J Ophthalmol 86:716\u2013722","journal-title":"Br J Ophthalmol"},{"key":"9069_CR5","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nrn2007","volume":"7","author":"A Rattner","year":"2006","unstructured":"Rattner A, Nathans J (2006) Macular degeneration: recent advances and therapeutic opportunities. Nat Rev Neurosci 7:860\u2013872","journal-title":"Nat Rev Neurosci"},{"key":"9069_CR6","first-page":"214","volume-title":"Transpupillary thermotherapy for the treatment of choirodal neovascularization associated wth age-related macular degeneration. Age-related Macular Degeneration: A comprehensive Textook","author":"PE Liggett","year":"2006","unstructured":"Liggett PE, Lavaque AJ, Jablon EP, Reichel E, Quiroz-Mercado H (2006) Transpupillary thermotherapy for the treatment of choirodal neovascularization associated wth age-related macular degeneration. Age-related Macular Degeneration: A comprehensive Textook. Lippincott Williams and Wilkin, Philadelphia, pp. 214\u2013230"},{"key":"9069_CR7","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1080\/08820530490884173","volume":"19","author":"G Dorin","year":"2004","unstructured":"Dorin G (2004) Evolution of retinal laser therapy: minimum intensity photocoagulation (MIP). Can the laser heal the retina without harming it?. Semin Ophthalmol 19:62\u201368","journal-title":"Semin Ophthalmol"},{"key":"9069_CR8","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1136\/bjo.85.4.483","volume":"85","author":"G Soubrane","year":"2001","unstructured":"Soubrane G, Bressler NM (2001) Treatment of subfoveal choroidal neovascularisation in age related macular degeneration: focus on clinical application of verteporfin photodynamic therapy. Br J Ophthalmol 85:483\u2013495","journal-title":"Br J Ophthalmol"},{"key":"9069_CR9","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1056\/NEJMoa042760","volume":"351","author":"ES Gragoudas","year":"2004","unstructured":"Gragoudas ES, Adamis AP, Cunningham ET Jr., Feinsod M, Guyer DR (2004) Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 351:2805\u20132816","journal-title":"N Engl J Med"},{"key":"9069_CR10","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1097\/01.iae.0000242842.14624.e7","volume":"26","author":"N Ferrara","year":"2006","unstructured":"Ferrara N, Damico L, Shams N, Lowman H, Kim R (2006) Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration. Retina 26:859\u2013870","journal-title":"Retina"},{"key":"9069_CR11","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0008-4182(05)80078-X","volume":"40","author":"EW Ng","year":"2005","unstructured":"Ng EW, Adamis AP (2005) Targeting angiogenesis, the underlying disorder in neovascular age-related macular degeneration. Can J Ophthalmol 40:352\u2013368","journal-title":"Can J Ophthalmol"},{"key":"9069_CR12","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0002-9394(14)71402-3","volume":"116","author":"A Capone Jr.","year":"1993","unstructured":"Capone A Jr., Diaz-Rohena R, Sternberg P Jr., Mandell B, Lambert HM, Lopez PF (1993) Diode-laser photocoagulation for zone 1 threshold retinopathy of prematurity. Am J Ophthalmol 116:444\u2013450","journal-title":"Am J Ophthalmol"},{"key":"9069_CR13","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/j.1600-0420.2005.00623.x","volume":"84","author":"K Myint","year":"2006","unstructured":"Myint K, Armbrecht AM, Mon S, Dhillon B (2006) Transpupillary thermotherapy for the treatment of occult CNV in age-related macular degeneration: a prospective randomized controlled pilot study. Acta Ophthalmol Scand 84:328\u2013332","journal-title":"Acta Ophthalmol Scand"},{"key":"9069_CR14","doi-asserted-by":"crossref","unstructured":"(1991) Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology. 98:766\u2013785","DOI":"10.1016\/S0161-6420(13)38011-7"},{"key":"9069_CR15","doi-asserted-by":"crossref","unstructured":"(1991) Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics. ETDRS report number 7. Ophthalmology. 98:741\u2013756","DOI":"10.1016\/S0161-6420(13)38009-9"},{"key":"9069_CR16","first-page":"198","volume":"119","author":"NM Bressler","year":"2001","unstructured":"Bressler NM (2001) Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2. Arch Ophthalmol 119:198\u2013207","journal-title":"Arch Ophthalmol"},{"key":"9069_CR17","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0039-6257(00)00158-2","volume":"45","author":"U Schmidt-Erfurth","year":"2000","unstructured":"Schmidt-Erfurth U, Hasan T (2000) Mechanisms of action of photodynamic therapy with verteporfin for the treatment of age-related macular degeneration. Surv Ophthalmol 45:195\u2013214","journal-title":"Surv Ophthalmol"},{"key":"9069_CR18","doi-asserted-by":"publisher","first-page":"S146","DOI":"10.2307\/3579816","volume":"150","author":"NL Oleinick","year":"1998","unstructured":"Oleinick NL, Evans HH (1998) The photobiology of photodynamic therapy: cellular targets and mechanisms. Radiat Res 150:S146\u2013156","journal-title":"Radiat Res"},{"key":"9069_CR19","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1001\/archopht.120.11.1443","volume":"120","author":"NM Bressler","year":"2002","unstructured":"Bressler NM, Arnold J, Benchaboune M, Blumenkranz MS, Fish GE, Gragoudas ES, Lewis H, Schmidt-Erfurth U, Slakter JS, Bressler SB, Manos K, Hao Y, Hayes L, Koester J, Reaves A, Strong HA (2002) Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: additional information regarding baseline lesion composition\u2019s impact on vision outcomes-TAP report No. 3. Arch Ophthalmol 120:1443\u20131454","journal-title":"Arch Ophthalmol"},{"key":"9069_CR20","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1097\/00006982-200502000-00001","volume":"25","author":"AP Adamis","year":"2005","unstructured":"Adamis AP, Shima DT (2005) The role of vascular endothelial growth factor in ocular health and disease. Retina 25:111\u2013118","journal-title":"Retina"},{"key":"9069_CR21","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.yexcr.2005.11.008","volume":"312","author":"YS Ng","year":"2006","unstructured":"Ng YS, Krilleke D, Shima DT (2006) VEGF function in vascular pathogenesis. Exp Cell Res 312:527\u2013537","journal-title":"Exp Cell Res"},{"key":"9069_CR22","doi-asserted-by":"publisher","first-page":"5018","DOI":"10.1158\/1078-0432.CCR-06-1520","volume":"12","author":"M Kowanetz","year":"2006","unstructured":"Kowanetz M, Ferrara N (2006) Vascular endothelial growth factor signaling pathways: therapeutic perspective. Clin Cancer Res 12:5018\u20135022","journal-title":"Clin Cancer Res"},{"key":"9069_CR23","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nrd1955","volume":"5","author":"EW Ng","year":"2006","unstructured":"Ng EW, Shima DT, Calias P, Cunningham ET Jr., Guyer DR, Adamis AP (2006) Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease. Nat Rev Drug Discov 5:123\u2013132","journal-title":"Nat Rev Drug Discov"},{"key":"9069_CR24","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1056\/NEJMoa062655","volume":"355","author":"DM Brown","year":"2006","unstructured":"Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY, Sy JP, Schneider S (2006) Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 355:1432\u20131444","journal-title":"N Engl J Med"},{"key":"9069_CR25","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1056\/NEJMoa054481","volume":"355","author":"PJ Rosenfeld","year":"2006","unstructured":"Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY (2006) Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355:1419\u20131431","journal-title":"N Engl J Med"},{"key":"9069_CR26","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1136\/bjo.2006.099598","volume":"90","author":"AE Fung","year":"2006","unstructured":"Fung AE, Rosenfeld PJ, Reichel E (2006) The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide. Br J Ophthalmol 90:1344\u20131349","journal-title":"Br J Ophthalmol"},{"key":"9069_CR27","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1172\/JCI200317929","volume":"111","author":"G Bergers","year":"2003","unstructured":"Bergers G, Song S, Meyer-Morse N, Bergsland E, Hanahan D (2003) Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. J Clin Invest 111:1287\u20131295","journal-title":"J Clin Invest"},{"key":"9069_CR28","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.2353\/ajpath.2006.050588","volume":"168","author":"N Jo","year":"2006","unstructured":"Jo N, Mailhos C, Ju M, Cheung E, Bradley J, Nishijima K, Robinson GS, Adamis AP, Shima DT (2006) Inhibition of platelet-derived growth factor B signaling enhances the efficacy of anti-vascular endothelial growth factor therapy in multiple models of ocular neovascularization. Am J Pathol 168:2036\u20132053","journal-title":"Am J Pathol"},{"key":"9069_CR29","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.ajo.2005.07.025","volume":"141","author":"RF Spaide","year":"2006","unstructured":"Spaide RF (2006) Rationale for combination therapies for choroidal neovascularization. Am J Ophthalmol 141:149\u2013156","journal-title":"Am J Ophthalmol"},{"key":"9069_CR30","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0039-6257(03)00030-4","volume":"48","author":"J Ambati","year":"2003","unstructured":"Ambati J, Ambati BK, Yoo SH, Ianchulev S, Adamis AP (2003) Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv Ophthalmol 48:257\u2013293","journal-title":"Surv Ophthalmol"},{"key":"9069_CR31","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1136\/bjo.2003.027177","volume":"88","author":"E Rechtman","year":"2004","unstructured":"Rechtman E, Danis RP, Pratt LM, Harris A (2004) Intravitreal triamcinolone with photodynamic therapy for subfoveal choroidal neovascularisation in age related macular degeneration. Br J Ophthalmol 88:344\u2013347","journal-title":"Br J Ophthalmol"},{"key":"9069_CR32","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1016\/S0161-6420(03)00544-X","volume":"110","author":"RF Spaide","year":"2003","unstructured":"Spaide RF, Sorenson J, Maranan L (2003) Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization. Ophthalmology 110:1517\u20131525","journal-title":"Ophthalmology"},{"key":"9069_CR33","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/archopht.120.10.1307","volume":"120","author":"MS Blumenkranz","year":"2002","unstructured":"Blumenkranz MS, Bressler NM, Bressler SB, Donati G, Fish GE, Haynes LA, Lewis H, Miller JW, Mones JM, Potter MJ, Pournaras C, Reaves A, Rosenfeld PJ, Schachat AP, Schmidt-Erfurth U, Sickenburg M, Singerman LJ, Slakter JS, Strong A, Vannier S (2002) Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: three-year results of an open-label extension of 2 randomized clinical trials\u2013TAP Report no. 5. Arch Ophthalmol 120:1307\u20131314","journal-title":"Arch Ophthalmol"},{"issue":"Pt 2","key":"9069_CR34","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/eye.1998.62","volume":"12","author":"CJ Flaxel","year":"1998","unstructured":"Flaxel CJ, Owens SL, Mulholland B, Schwartz SD, Gregor ZJ (1998) The use of corticosteroids for choroidal neovascularisation in young patients. Eye 12(Pt 2):266\u2013272","journal-title":"Eye"},{"key":"9069_CR35","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1089\/jop.1999.15.425","volume":"15","author":"A Martidis","year":"1999","unstructured":"Martidis A, Miller DG, Ciulla TA, Danis RP, Moorthy RS (1999) Corticosteroids as an antiangiogenic agent for histoplasmosis-related subfoveal choroidal neovascularization. J Ocul Pharmacol Ther 15:425\u2013428","journal-title":"J Ocul Pharmacol Ther"},{"key":"9069_CR36","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1136\/bjo.2004.063024","volume":"89","author":"A Hogan","year":"2005","unstructured":"Hogan A, Behan U, Kilmartin DJ (2005) Outcomes after combination photodynamic therapy and immunosuppression for inflammatory subfoveal choroidal neovascularisation. Br J Ophthalmol 89:1109\u20131111","journal-title":"Br J Ophthalmol"},{"key":"9069_CR37","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ophtha.2005.09.002","volume":"113","author":"AJ Augustin","year":"2006","unstructured":"Augustin AJ, Schmidt-Erfurth U (2006) Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration. Ophthalmology 113:14\u201322","journal-title":"Ophthalmology"},{"key":"9069_CR38","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.ajo.2005.11.058","volume":"141","author":"AJ Augustin","year":"2006","unstructured":"Augustin AJ, Schmidt-Erfurth U (2006) Verteporfin and intravitreal triamcinolone acetonide combination therapy for occult choroidal neovascularization in age-related macular degeneration. Am J Ophthalmol 141:638\u2013645","journal-title":"Am J Ophthalmol"},{"key":"9069_CR39","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1136\/bjo.2006.090852","volume":"90","author":"K Petermeier","year":"2006","unstructured":"Petermeier K, Tatar O, Inhoffen W, Volker M, Lafaut BA, Henke-Fahle S, Gelisken F, Ziemssen F, Bopp S, Bartz-Schmidt KU, Grisanti S (2006) Verteporfin photodynamic therapy induced apoptosis in choroidal neovascular membranes. Br J Ophthalmol 90:1034\u20131039","journal-title":"Br J Ophthalmol"},{"key":"9069_CR40","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1001\/archopht.123.4.509","volume":"123","author":"D Husain","year":"2005","unstructured":"Husain D, Kim I, Gauthier D, Lane AM, Tsilimbaris MK, Ezra E, Connolly EJ, Michaud N, Gragoudas ES, O\u2019Neill CA, Beyer JC, Miller JW (2005) Safety and efficacy of intravitreal injection of ranibizumab in combination with verteporfin PDT on experimental choroidal neovascularization in the monkey. Arch Ophthalmol 123:509\u2013516","journal-title":"Arch Ophthalmol"},{"key":"9069_CR41","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1167\/iovs.04-0087","volume":"47","author":"IK Kim","year":"2006","unstructured":"Kim IK, Husain D, Michaud N, Connolly E, Lane AM, Durrani K, Hafezi-Moghadam A, Gragoudas ES, O\u2019Neill CA, Beyer JC, Miller JW (2006) Effect of intravitreal injection of ranibizumab in combination with verteporfin PDT on normal primate retina and choroid. Invest Ophthalmol Vis Sci 47:357\u2013363","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"9069_CR42","doi-asserted-by":"crossref","unstructured":"Zuluaga M-F, Mailhos C, Robinson GS, Shima DT, Gurny R, Lange N (2006) VEGF inhibition enhances the effects of photodynamic therapy for age-related macular degeneration. Invest Ophthalmol Vis Sci","DOI":"10.1167\/iovs.06-1224"},{"key":"9069_CR43","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1001\/archopht.124.11.1532","volume":"124","author":"JS Heier","year":"2006","unstructured":"Heier JS, Boyer DS, Ciulla TA, Ferrone PJ, Jumper JM, Gentile RC, Kotlovker D, Chung CY, Kim RY (2006) Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration: year 1 results of the FOCUS Study. Arch Ophthalmol 124:1532\u20131542","journal-title":"Arch Ophthalmol"},{"key":"9069_CR44","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1097\/01.iae.0000247164.70376.91","volume":"26","author":"MS Dhalla","year":"2006","unstructured":"Dhalla MS, Shah GK, Blinder KJ, Ryan EH Jr., Mittra RA, Tewari A (2006) Combined photodynamic therapy with verteporfin and intravitreal bevacizumab for choroidal neovascularization in age-related macular degeneration. Retina 26:988\u2013993","journal-title":"Retina"},{"key":"9069_CR45","doi-asserted-by":"publisher","first-page":"4307","DOI":"10.1093\/emboj\/cdf418","volume":"21","author":"M Enge","year":"2002","unstructured":"Enge M, Bjarnegard M, Gerhardt H, Gustafsson E, Kalen M, Asker N, Hammes HP, Shani M, Fassler R, Betsholtz C (2002) Endothelium-specific platelet-derived growth factor-B ablation mimics diabetic retinopathy. Embo J 21:4307\u20134316","journal-title":"Embo J"},{"key":"9069_CR46","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00441-003-0745-x","volume":"314","author":"H Gerhardt","year":"2003","unstructured":"Gerhardt H, Betsholtz C (2003) Endothelial-pericyte interactions in angiogenesis. Cell Tissue Res 314:15\u201323","journal-title":"Cell Tissue Res"},{"key":"9069_CR47","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1080\/01926230600936290","volume":"34","author":"AP Hall","year":"2006","unstructured":"Hall AP (2006) Review of the pericyte during angiogenesis and its role in cancer and diabetic retinopathy. Toxicol Pathol 34:763\u2013775","journal-title":"Toxicol Pathol"},{"key":"9069_CR48","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0002-9440(10)64920-6","volume":"160","author":"S Morikawa","year":"2002","unstructured":"Morikawa S, Baluk P, Kaidoh T, Haskell A, Jain RK, McDonald DM (2002) Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors. Am J Pathol 160:985\u20131000","journal-title":"Am J Pathol"},{"key":"9069_CR49","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1096\/fj.03-0271fje","volume":"18","author":"R Erber","year":"2004","unstructured":"Erber R, Thurnher A, Katsen AD, Groth G, Kerger H, Hammes HP, Menger MD, Ullrich A, Vajkoczy P (2004) Combined inhibition of VEGF and PDGF signaling enforces tumor vessel regression by interfering with pericyte-mediated endothelial cell survival mechanisms. Faseb J 18:338\u2013340","journal-title":"Faseb J"},{"issue":"Suppl 5","key":"9069_CR50","doi-asserted-by":"publisher","first-page":"S77","DOI":"10.1016\/S0959-8049(02)80607-4","volume":"38","author":"R Capdeville","year":"2002","unstructured":"Capdeville R, Silberman S, Dimitrijevic S (2002) Imatinib: the first 3\u00a0years. Eur J Cancer 38(Suppl 5):S77\u201382","journal-title":"Eur J Cancer"},{"key":"9069_CR51","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/jcp.10246","volume":"195","author":"Y Saishin","year":"2003","unstructured":"Saishin Y, Saishin Y, Takahashi K, Lima e Silva R, Hylton D, Rudge JS, Wiegand SJ, Campochiaro PA (2003) VEGF-TRAP(R1R2) suppresses choroidal neovascularization and VEGF-induced breakdown of the blood-retinal barrier. J Cell Physiol 195:241\u2013248","journal-title":"J Cell Physiol"},{"key":"9069_CR52","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/nchembio839","volume":"2","author":"D Bumcrot","year":"2006","unstructured":"Bumcrot D, Manoharan M, Koteliansky V, Sah DW (2006) RNAi therapeutics: a potential new class of pharmaceutical drugs. Nat Chem Biol 2:711\u2013719","journal-title":"Nat Chem Biol"},{"key":"9069_CR53","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1056\/NEJMoa041773","volume":"353","author":"D Watanabe","year":"2005","unstructured":"Watanabe D, Suzuma K, Matsui S, Kurimoto M, Kiryu J, Kita M, Suzuma I, Ohashi H, Ojima T, Murakami T, Kobayashi T, Masuda S, Nagao M, Yoshimura N, Takagi H (2005) Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy. N Engl J Med 353:782\u2013792","journal-title":"N Engl J Med"},{"key":"9069_CR54","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.ajo.2004.09.058","volume":"139","author":"NN Markomichelakis","year":"2005","unstructured":"Markomichelakis NN, Theodossiadis PG, Sfikakis PP (2005) Regression of neovascular age-related macular degeneration following infliximab therapy. Am J Ophthalmol 139:537\u2013540","journal-title":"Am J Ophthalmol"},{"key":"9069_CR55","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1097\/00006982-200512000-00015","volume":"25","author":"W Hu","year":"2005","unstructured":"Hu W, Criswell MH, Ottlecz A, Cornell TL, Danis RP, Lambrou GN, Ciulla TA (2005) Oral administration of lumiracoxib reduces choroidal neovascular membrane development in the rat laser-trauma model. Retina 25:1054\u20131064","journal-title":"Retina"},{"key":"9069_CR56","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0002-9440(10)63311-1","volume":"165","author":"V Poulaki","year":"2004","unstructured":"Poulaki V, Joussen AM, Mitsiades N, Mitsiades CS, Iliaki EF, Adamis AP (2004) Insulin-like growth factor-I plays a pathogenetic role in diabetic retinopathy. Am J Pathol 165:457\u2013469","journal-title":"Am J Pathol"}],"container-title":["Angiogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10456-007-9069-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10456-007-9069-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10456-007-9069-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10456-007-9069-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,15]],"date-time":"2022-05-15T07:02:19Z","timestamp":1652598139000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10456-007-9069-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3,13]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["9069"],"URL":"https:\/\/doi.org\/10.1007\/s10456-007-9069-x","relation":{},"ISSN":["0969-6970","1573-7209"],"issn-type":[{"value":"0969-6970","type":"print"},{"value":"1573-7209","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3,13]]},"assertion":[{"value":"23 January 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2007","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2007","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}